Rankings
▼
Calendar
TLSI FY 2024 Earnings — TriSalus Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena
TLSI
TriSalus Life Sciences, Inc.
$175M
FY 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$29M
+59.0% YoY
Gross Profit
$25M
86.1% margin
Operating Income
-$36M
-122.9% margin
Net Income
-$33M
-112.9% margin
EPS (Diluted)
$-1.25
Cash Flow
Operating Cash Flow
-$41M
Free Cash Flow
-$41M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$24M
Total Liabilities
$50M
Stockholders' Equity
-$26M
Cash & Equivalents
$9M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$29M
$19M
+59.0%
Gross Profit
$25M
$16M
+59.2%
Operating Income
-$36M
-$54M
+33.6%
Net Income
-$33M
-$59M
+44.0%
← Q4 2023
All Quarters
Q1 2024 →